Michael Attar (Past Speaker)

Michael joined Celgene’s Business Development team following the company’s acquisition of Abraxis BioScience in the fall of 2010.  In the 3+ years Michael has been with Celgene, he has successfully completed 8 transactions and has taken the lead from a BD perspective in putting in place the company’s biologics collaborations, including deals announced with OncoMed, Adimab, AnaptysBio, Inhibrx and Sutro Biopharma.  Michael joined Abraxis in early 2008, and among other accomplishments, helped establish the Abraxis commercial presence in China and helped lead the commercial launch of Abraxane in that market.  Prior to joining Abraxis, Michael was involved in the tech / telecom area, working for two technology companies in southern California.  Prior to these engagements, Michael was a sell-side Research Analyst at Morgan Stanley covering the wireless telecom space.  Michael received his undergraduate degree from the Johns Hopkins University and his MBA from the Kellogg School of Management at Northwestern University.